<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36415739</PMID><DateRevised><Year>2022</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2516-8290</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>10</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Access microbiology</Title><ISOAbbreviation>Access Microbiol</ISOAbbreviation></Journal><ArticleTitle>Co-infection of SARS-CoV-2 with other respiratory pathogens in patients with liver disease.</ArticleTitle><Pagination><StartPage>acmi000456</StartPage><MedlinePgn>acmi000456</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">acmi000456</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1099/acmi.0.000456</ELocationID><Abstract><AbstractText>Respiratory illness caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) was first documented in Wuhan, China, in December 2019, followed by its rapid spread across the globe. Accumulating evidence has demonstrated viral/bacterial co-infection in the respiratory tract could modulate disease severity and its outcome in COVID-19 infection. In this retrospective study, 300 chronic liver disease patients with radiologically confirmed lower respiratory tract infection were enrolled from September 2020 to December 2021. In all of them, along with SARS-CoV-2, other respiratory viral/bacterial pathogens were studied. In total, 23.7&#x200a;% (<i>n</i>=71) patients were positive for SARS-CoV-2. Among the positive patients, 23.9&#x200a;% (<i>n</i>=17) had co-infection with other respiratory pathogens, bacterial co-infections being dominant. The SARS-CoV-2 negative cohort had 39.7&#x200a;&#x200a;% positivity (<i>n</i>=91) for other respiratory pathogens, the most common being those of the rhinovirus/enterovirus family. Ground glass opacity (GGO) with consolidation was found to be the most common radiological finding among SARS-CoV-2 positive co-infected patients, as compared to only GGO among SARS-CoV-2 mono-infected patients. Accurate diagnosis of co-infections, especially during pandemics including COVID-19, can ameliorate the treatment and management of suspected cases.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Samal</LastName><ForeName>Jasmine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Virology, Institute of Liver and Biliary Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agarwal</LastName><ForeName>Reshu</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Clinical Virology, Institute of Liver and Biliary Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soni</LastName><ForeName>Anushka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Virology, Institute of Liver and Biliary Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pandey</LastName><ForeName>Amit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Virology, Institute of Liver and Biliary Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thapar</LastName><ForeName>Shalini</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Radiology, Institute of Liver and Biliary Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Ekta</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-5237-216X</Identifier><AffiliationInfo><Affiliation>Department of Clinical Virology, Institute of Liver and Biliary Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Access Microbiol</MedlineTA><NlmUniqueID>101746927</NlmUniqueID><ISSNLinking>2516-8290</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HRCT</Keyword><Keyword MajorTopicYN="N">LRTI</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">co-infection</Keyword><Keyword MajorTopicYN="N">liver disease</Keyword><Keyword MajorTopicYN="N">respiratory viral infection</Keyword></KeywordList><CoiStatement>The authors declare that there are no conflicts of interest</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>23</Day><Hour>2</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36415739</ArticleId><ArticleId IdType="pmc">PMC9675177</ArticleId><ArticleId IdType="doi">10.1099/acmi.0.000456</ArticleId><ArticleId IdType="pii">000456</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Li B, Yang J, Zhao F, Zhi L, Wang X, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109:531&#x2013;538. doi: 10.1007/s00392-020-01626-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-020-01626-9</ArticleId><ArticleId IdType="pmc">PMC7087935</ArticleId><ArticleId IdType="pubmed">32161990</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  Geneva: World Health Organization; 2021. Novel coronavirus (2019-nCoV) situation reports [29 Nov 2021]https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports</Citation></Reference><Reference><Citation>Morens DM, Daszak P, Markel H, Taubenberger JK. Pandemic COVID-19 joins history&#x2019;s pandemic legion. mBio. 2020;11:e00812-20. doi: 10.1128/mBio.00812-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00812-20</ArticleId><ArticleId IdType="pmc">PMC7267883</ArticleId><ArticleId IdType="pubmed">32471830</ArticleId></ArticleIdList></Reference><Reference><Citation>Memish ZA, Perlman S, Van Kerkhove MD, Zumla A. Middle East respiratory syndrome. Lancet. 2020;395:1063&#x2013;1077. doi: 10.1016/S0140-6736(19)33221-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)33221-0</ArticleId><ArticleId IdType="pmc">PMC7155742</ArticleId><ArticleId IdType="pubmed">32145185</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19:141&#x2013;154. doi: 10.1038/s41579-020-00459-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A, Tiwari S, Deb MK, Marty JL. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies. Int J Antimicrob Agents. 2020;56:106054. doi: 10.1016/j.ijantimicag.2020.106054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.106054</ArticleId><ArticleId IdType="pmc">PMC7286265</ArticleId><ArticleId IdType="pubmed">32534188</ArticleId></ArticleIdList></Reference><Reference><Citation>Westblade LF, Simon MS, Satlin MJ. Bacterial coinfections in coronavirus disease 2019. Trends Microbiol. 2021;29:930&#x2013;941. doi: 10.1016/j.tim.2021.03.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2021.03.018</ArticleId><ArticleId IdType="pmc">PMC8026275</ArticleId><ArticleId IdType="pubmed">33934980</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang AJ, Lee A-Y, Chan J-W, Liu F, Li C, et al. Coinfection by severe acute respiratory syndrome coronavirus 2 and influenza A(H1N1)pdm09 virus enhances the severity of pneumonia in golden Syrian hamsters. Clin Infect Dis. 2021;72:e978&#x2013;e992. doi: 10.1093/cid/ciaa1747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1747</ArticleId><ArticleId IdType="pmc">PMC7717201</ArticleId><ArticleId IdType="pubmed">33216851</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Ling L, Wong SH, Wang MH, Fitzgerald JR, et al. Outcomes of respiratory viral-bacterial co-infection in adult hospitalized patients. EClinicalMedicine. 2021;37:100955. doi: 10.1016/j.eclinm.2021.100955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100955</ArticleId><ArticleId IdType="pmc">PMC8343259</ArticleId><ArticleId IdType="pubmed">34386745</ArticleId></ArticleIdList></Reference><Reference><Citation>Musuuza JS, Watson L, Parmasad V, Putman-Buehler N, Christensen L, et al. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis. PLoS One. 2021;16:e0251170. doi: 10.1371/journal.pone.0251170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0251170</ArticleId><ArticleId IdType="pmc">PMC8101968</ArticleId><ArticleId IdType="pubmed">33956882</ArticleId></ArticleIdList></Reference><Reference><Citation>Metzger DW, Sun K. Immune dysfunction and bacterial coinfections following influenza. J Immunol. 2013;191:2047&#x2013;2052. doi: 10.4049/jimmunol.1301152.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1301152</ArticleId><ArticleId IdType="pmc">PMC3760235</ArticleId><ArticleId IdType="pubmed">23964104</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar N, Sharma S, Barua S, Tripathi BN, Rouse BT. Virological and immunological outcomes of coinfections. Clin Microbiol Rev. 2018;31:e00111-17. doi: 10.1128/CMR.00111-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00111-17</ArticleId><ArticleId IdType="pmc">PMC6148187</ArticleId><ArticleId IdType="pubmed">29976554</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA. 2020;323:2085&#x2013;2086. doi: 10.1001/jama.2020.6266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6266</ArticleId><ArticleId IdType="pmc">PMC7160748</ArticleId><ArticleId IdType="pubmed">32293646</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang G, Hu C, Luo L, Fang F, Chen Y, et al. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. J Clin Virol. 2020;127:104364. doi: 10.1016/j.jcv.2020.104364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104364</ArticleId><ArticleId IdType="pmc">PMC7194884</ArticleId><ArticleId IdType="pubmed">32311650</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang S, Liu P, Xiong G, Yang Z, Wang M, et al. Coinfection of SARS-CoV-2 and multiple respiratory pathogens in children. Clin Chem Lab Med. 2020;58:1160&#x2013;1161. doi: 10.1515/cclm-2020-0434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2020-0434</ArticleId><ArticleId IdType="pubmed">32301747</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrel S, Hausfater P, Dres M, Pourcher V, Luyt C-E, et al. Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19. Int J Infect Dis. 2021;102:10&#x2013;13. doi: 10.1016/j.ijid.2020.10.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.10.040</ArticleId><ArticleId IdType="pmc">PMC7585729</ArticleId><ArticleId IdType="pubmed">33115679</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreenath K, Batra P, Vinayaraj EV, Bhatia R, SaiKiran K, et al. Coinfections with other respiratory pathogens among patients with COVID-19. Microbiol Spectr. 2021;9:e0016321. doi: 10.1128/Spectrum.00163-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/Spectrum.00163-21</ArticleId><ArticleId IdType="pmc">PMC8552727</ArticleId><ArticleId IdType="pubmed">34287033</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L, Wang W, Le Grange JM, Wang X, Du S, et al. Coinfection of SARS-CoV-2 and other respiratory pathogens. Infect Drug Resist. 2020;13:3045&#x2013;3053. doi: 10.2147/IDR.S267238.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S267238</ArticleId><ArticleId IdType="pmc">PMC7457866</ArticleId><ArticleId IdType="pubmed">32922049</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosch A, Biesbroek G, Trzcinski K, Sanders EAM, Bogaert D. Viral and bacterial interactions in the upper respiratory tract. PLoS Pathog. 2013;9:e1003057. doi: 10.1371/journal.ppat.1003057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003057</ArticleId><ArticleId IdType="pmc">PMC3542149</ArticleId><ArticleId IdType="pubmed">23326226</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall NC, Kariyawasam RM, Zelyas N, Kanji JN, Diggle MA. Broad respiratory testing to identify SARS-CoV-2 viral co-circulation and inform diagnostic stewardship in the COVID-19 pandemic. Virol J. 2021;18:93. doi: 10.1186/s12985-021-01545-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-021-01545-9</ArticleId><ArticleId IdType="pmc">PMC8087885</ArticleId><ArticleId IdType="pubmed">33933115</ArticleId></ArticleIdList></Reference><Reference><Citation>Contou D, Claudinon A, Pajot O, Mica&#xeb;lo M, Longuet Flandre P, et al. Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU. Ann Intensive Care. 2020;10:119. doi: 10.1186/s13613-020-00736-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-020-00736-x</ArticleId><ArticleId IdType="pmc">PMC7475952</ArticleId><ArticleId IdType="pubmed">32894364</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhry R, Sreenath K, Batra P, Vinayaraj EV, Rathor N, et al. Atypical bacterial co-infections among patients with COVID-19: a study from India. J Med Virol. 2022;94:303&#x2013;309. doi: 10.1002/jmv.27324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27324</ArticleId><ArticleId IdType="pmc">PMC8661859</ArticleId><ArticleId IdType="pubmed">34491594</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, Sahni S, Siddiqui S, Mishra N, Sharma P, et al. Respiratory co-infections: modulators of SARS-CoV-2 patients&#x2019; clinical sub-phenotype. Front Microbiol. 2021;12:653399. doi: 10.3389/fmicb.2021.653399.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.653399</ArticleId><ArticleId IdType="pmc">PMC8193731</ArticleId><ArticleId IdType="pubmed">34122366</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R. The COVID-19 cytokine storm; what we know so far. Front Immunol. 2020;11:1446. doi: 10.3389/fimmu.2020.01446.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01446</ArticleId><ArticleId IdType="pmc">PMC7308649</ArticleId><ArticleId IdType="pubmed">32612617</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai CC, Wang CY, Hsueh PR. Co-infections among patients with COVID-19: the need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect. 2020;53:505&#x2013;512. doi: 10.1016/j.jmii.2020.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2020.05.013</ArticleId><ArticleId IdType="pmc">PMC7245213</ArticleId><ArticleId IdType="pubmed">32482366</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu J, Chang LK, Tang X, Du Y, Yang X, et al. Clinical characteristics of COVID-19 and its comparison with influenza pneumonia. Acta Clin Belg. 2020;75:348&#x2013;356. doi: 10.1080/17843286.2020.1798668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17843286.2020.1798668</ArticleId><ArticleId IdType="pubmed">32723027</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu M, Xu D, Lan L, Tu M, Liao R, et al. Thin-section chest CT imaging of COVID-19 pneumonia: a comparison between patients with mild and severe disease. Radiol Cardiothorac Imaging. 2020;2:e200126. doi: 10.1148/ryct.2020200126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/ryct.2020200126</ArticleId><ArticleId IdType="pmc">PMC7233444</ArticleId><ArticleId IdType="pubmed">33778568</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacedonia D, Quarato CMI, Mirijello A, Trovato GM, Del Colle A, et al. COVID-19 pneumonia: the great ultrasonography mimicker. Front Med. 2021;8:709402. doi: 10.3389/fmed.2021.709402.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.709402</ArticleId><ArticleId IdType="pmc">PMC8424049</ArticleId><ArticleId IdType="pubmed">34513877</ArticleId></ArticleIdList></Reference><Reference><Citation>Hani C, Trieu NH, Saab I, Dangeard S, Bennani S, et al. COVID-19 pneumonia: a review of typical CT findings and differential diagnosis. Diagn Interv Imaging. 2020;101:263&#x2013;268. doi: 10.1016/j.diii.2020.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diii.2020.03.014</ArticleId><ArticleId IdType="pmc">PMC7129663</ArticleId><ArticleId IdType="pubmed">32291197</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>